Introduction
Galen Growth is pleased to share with you our 2024 Global Analysis on Digital Health Funding, Key Trends and Innovation. We look across the global startup ecosystem for Digital Health and explain the current trends that are driving demand. Our analysis focuses on private ventures and includes ecosystem growth, most active partners, regulatory approvals and venture funding.
This report, powered by HealthTech Alpha- a Galen Growth proprietary solution and the world’s leading Digital Health private market data, intel, and insights platform- offers unmatched, non-biased, non-hyped, and data-driven coverage of the global Digital Health ecosystems.
Key insights from the report
- Robust Investment: The Digital Health sector showed remarkable resilience in 2024, reversing a two-year decline in funding with $25.1 billion raised across 1,600+ deals, reflecting a 5.5% growth year-over-year.
- Mega Deals (38%): 54 transactions exceeding $100M represented 38% of global funding, showcasing a focus on scalable ventures and recovery of mega deals.
- AI-Driven Investments (49%): Nearly half of all Digital Health funding targeted TechBio, Health Management Solutions and Medical Diagnostics. The substantial investment in these top 3 clusters emphasizes the surge in AI-driven research and healthcare tools in 2024.
- Health Systems Partnerships (21%): Over 3,150 collaborations with Digital Health ventures were announced in 2024. Health systems accounted for 21% of all partnerships, as providers seek to enhance patient care and operational efficiency.
- Venture M&A Surge (69%): Exit activity surged, with a 5% rise in mergers and acquisitions. 69% of deals focused on venture-to-venture consolidations.
Why it matters
The 2024 Global Analysis on Digital Health Funding, Key Trends, and Innovation is a must-read for stakeholders navigating the rapidly evolving healthcare landscape. Here's why this report is critical:
- Data-Driven Insights: Powered by HealthTech Alpha, this report offers unparalleled, non-biased coverage of the global Digital Health ecosystem, enabling decision-makers to act on reliable data rather than speculation.
- Resilience and Recovery: After a challenging period, the $25.1 billion raised in 2024 signals a renewed confidence in the sector, highlighting its ability to adapt and innovate amid changing market dynamics.
- AI-Led Transformation: With 49% of investments targeting AI-driven clusters like TechBio and Medical Diagnostics, the report sheds light on the technologies that are reshaping the future of healthcare delivery and research.
- Strategic Collaborations: Over 3,150 partnerships, with health systems accounting for 21%, reveal how collaboration is becoming essential for improving patient outcomes and operational efficiency.
- Market Consolidation: The surge in M&A activity (69% of deals being venture-to-venture consolidations) indicates a maturing market and the drive for scalable, impactful solutions.
Ventures and companies covered in this report
The “Digital Health 2024 Funding and Key Trends” report includes data on the following companies: Sword Health, Xaira Therapeutics, Included Health, Hinge Health, Medable, Aledade, Spring Health, Omada Health, Virta Health, Cityblock Health, Color Health, Lyra Health, Oura, Innovaccer, Fabric, Soda Health, Infinitus, HealthifyMe, Freya Biosciences, Centaur Labs, SandboxAQ, Freenome, Alan, Kestra Medical Technologies, Foodsmart, Blackrock Neurotech, Flo Health, AstraZeneca, Daiichi Sankyo, Italfarmaco, Samsung Life Insurance, NVIDIA, Mayo Clinic, Lilly, Pfizer, Roche, Novo Nordisk, Sanofi, General Catalyst, Andreessen Horowitz, Khosla Ventures, Bill & Melinda Gates Foundation, Alumni VenturesThis report is powered by HealthTech Alpha, the premier digital health intelligence platform delivering unparalleled data and insights into the evolving healthcare technology landscape. By leveraging its extensive database of over 14,000 ventures and cutting-edge analytics, HealthTech Alpha provides a data-driven foundation to analyze the critical trends and innovations shaping the future of medtech.
Designed to empower stakeholders—including investors, pharmaceutical leaders, and medical device manufacturers—HealthTech Alpha offers actionable intelligence to navigate the complexities of digital transformation in healthcare. This collaboration brings readers a comprehensive view of the intersection between digital health and medtech, equipping them with the insights needed to identify opportunities, assess market dynamics, and make strategic decisions in this rapidly advancing industry.
